Article

Artificial sight used for the first time in Europe

A blind person's sight was restored by surgeons at the University Hospitals of Geneva (HUG) for the first time in Europe using American technology.

Geneva, Switzerland-A blind person's sight was restored by surgeons at the University Hospitals of Geneva (HUG) for the first time in Europe using American technology.

Believed to be only the 10th procedure of its kind performed in the world, the technology was developed by Second Sight, a California-based company.

A tiny camera and transmitter are mounted in eyeglasses and an implanted receiver, and a device containing 60 electrodes is secured to the retina with a wire the width of a human hair.

"This kind of implant is suitable for people who suffer from a well-defined malady, retinitis pigmentosa," said Avinoam Safran, chief doctor at HUG's Ophthalmology Department. The technology is not expected to restore vision completely to the patient, he noted.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times) NeuroOp Guru: Using OCT to forecast outcomes in ethambutol optic neuropathy
(Image credit: Ophthalmology Times) Inside NYEE’s new refractive solutions center with Kira Manusis, MD
(Image credit: Ophthalmology Times) Dilsher Dhoot, MD, on the evolution of geographic atrophy therapy: where are we now?
(Image credit: Ophthalmology Times Europe) Anat Loewenstein, MD, shares insights on the real-world results of remote retinal imaging
(Image credit: Ophthalmology Times) Two-wavelength autofluorescence for macular xanthophyll carotenoids with Christine Curcio, PhD
(Image credit: Ophthalmology Times) FLIO and the brain: Making the invisible visible with Robert Sergott, MD
(Image credit: Ophthalmology Times) Structure-function correlates using high-res OCT images with Karl Csaky, MD, PhD
(Image credit: Ophthalmology Times) SriniVas Sadda, MD, on high-res OCT of atrophic and precursor lesions in AMD
(Image credit: Ophthalmology Times) Christine Curcio, PhD, shares histology update supporting review software and revised nomenclature for <3 μm OCT
© 2025 MJH Life Sciences

All rights reserved.